HomeAI · summaries
Storia in 3 fonti
FDA approves oral Utebzi for complicated UTIs
The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral treatment options,” the agency announced.Utebzi (tebipenem pivoxil, GSK and Spero Therapeutics) is the first oral carbapenem antibiotic approved for complicated UTIs in the United States. It is the second complicated
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves oral Utebzi for complicated UTIs
The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral…
- ·
medpagetoday.com
First Oral Carbapenem Approved for Complicated UTIs
Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients
- ·
benzinga.com
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs - GSK (NYSE:GSK), S
FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.